BRPI0518109A - cepa bacteriana, nucleocapsìdeo, preparação de vacina, método para criar uma bactéria recombinante, bactéria mutante, seqüências de rna fluorado para deslanchar rdsrna e meio para eletroporação - Google Patents

cepa bacteriana, nucleocapsìdeo, preparação de vacina, método para criar uma bactéria recombinante, bactéria mutante, seqüências de rna fluorado para deslanchar rdsrna e meio para eletroporação

Info

Publication number
BRPI0518109A
BRPI0518109A BRPI0518109-7A BRPI0518109A BRPI0518109A BR PI0518109 A BRPI0518109 A BR PI0518109A BR PI0518109 A BRPI0518109 A BR PI0518109A BR PI0518109 A BRPI0518109 A BR PI0518109A
Authority
BR
Brazil
Prior art keywords
bacterium
creating
bacteria
rna sequences
vaccine preparation
Prior art date
Application number
BRPI0518109-7A
Other languages
English (en)
Inventor
David Michael Hone
John Fulkerson
Jerald C Sadoff
David Onyabe
Michele Stone
Original Assignee
Aeras Global Tb Vaccine Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aeras Global Tb Vaccine Foundation filed Critical Aeras Global Tb Vaccine Foundation
Publication of BRPI0518109A publication Critical patent/BRPI0518109A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/25—Shigella (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

CEPA BACTERIANA, NUCLEOCAPSìDEOS, PREPARAçãO DE VACINA, MéTODO PARA CRIAR UMA BACTéRIA RECOMBINANTE, BACTéRIA MUTANTE, SEQUêNCIAS DE RNA FLUORADO PARA DESLANCHAR rdsRna E MEIO PARA ELETRO PORAçãO. A presente invenção se refere a cepas para englobar bactérias com utilidade na geracão de nucleocapsídeos recombínantes ce RNA de fita dupla (rdsRNs) são aqui proporcionadas. As cepas para englobar bactérias são de utilidade para a produção de antígenos de RNA para a codificação de vacinas, para proteínas bíoatívas, para proteínas imunoreguladoras, para RNAs antísentído e para RNAs catalíticos em células ou em tecidos eucaríótícos. O ssRNA recombínante é introduzido na cepa e é englobado para formar os rdsRNs de novo.
BRPI0518109-7A 2004-11-30 2005-11-23 cepa bacteriana, nucleocapsìdeo, preparação de vacina, método para criar uma bactéria recombinante, bactéria mutante, seqüências de rna fluorado para deslanchar rdsrna e meio para eletroporação BRPI0518109A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99907404A 2004-11-30 2004-11-30
US71372905P 2005-09-06 2005-09-06
PCT/US2005/042480 WO2006060257A2 (en) 2004-11-30 2005-11-23 Bacterial packaging strains usefuel for generation and production of recombinant double-stranded rna nucleocapsids and uses thereof

Publications (1)

Publication Number Publication Date
BRPI0518109A true BRPI0518109A (pt) 2008-11-04

Family

ID=36565556

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0518109-7A BRPI0518109A (pt) 2004-11-30 2005-11-23 cepa bacteriana, nucleocapsìdeo, preparação de vacina, método para criar uma bactéria recombinante, bactéria mutante, seqüências de rna fluorado para deslanchar rdsrna e meio para eletroporação

Country Status (13)

Country Link
US (1) US8053568B2 (pt)
EP (1) EP1817408B1 (pt)
JP (1) JP2008521434A (pt)
KR (1) KR20070101854A (pt)
AP (1) AP2007004020A0 (pt)
AU (1) AU2005310119A1 (pt)
BR (1) BRPI0518109A (pt)
CA (1) CA2587493A1 (pt)
EA (1) EA011282B1 (pt)
MX (1) MX2007006366A (pt)
PE (1) PE20061169A1 (pt)
TW (1) TW200631593A (pt)
WO (1) WO2006060257A2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU772356B2 (en) * 1998-12-04 2004-04-22 Aventis Pasteur Limited Two-step immunization procedure against chlamydia infection
WO2004050829A2 (en) * 2002-08-20 2004-06-17 Aeras Global Tuberculosis Vaccine Foundation Recombinant double-stranded rna phage, and use of the same
US20080107683A1 (en) * 2004-11-30 2008-05-08 David Hone Bacterial Packaging Strains Useful for Generation and Production of Recombinant Double-Stranded RNA Nucleocapsids and Uses Thereof
US7829104B2 (en) * 2004-12-01 2010-11-09 Aeras Global Tb Vaccine Foundation Electroporation of Mycobacterium and overexpression of antigens in mycobacteria
CN1276076C (zh) * 2004-12-14 2006-09-20 华东理工大学 一种鳗弧菌野生毒株的无标记基因缺失减毒突变株及其应用
WO2008127486A2 (en) * 2006-12-29 2008-10-23 Bacilligen, Inc. Replication-proficient dsrna capsids and uses thereof
EP3307308A2 (en) * 2015-06-10 2018-04-18 Hookipa Biotech AG Hpv vaccines
JP2021525760A (ja) * 2018-06-02 2021-09-27 シンロジック オペレーティング カンパニー インコーポレイテッド 肝疾患を処置するように操作された細菌
EP3863571B1 (en) * 2018-10-08 2026-03-18 Reflow Medical, Inc. Delivery systems for stents having protruding features

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736388A (en) * 1994-12-30 1998-04-07 Chada; Sunil Bacteriophage-mediated gene transfer systems capable of transfecting eukaryotic cells
IL123569A (en) * 1995-09-06 2006-10-05 Dept Of The Army Attenuated shigella strain for delivering a mamalian expression plasmid into a mammalian cell
US6887483B2 (en) * 1995-12-01 2005-05-03 University Of Iowa Research Foundation Non-toxic mutants of pathogenic gram-negative bacteria
EP1021548A1 (en) * 1997-10-07 2000-07-26 University Of Maryland Biotechnology Institute Method for introducing and expressing rna in animal cells
WO2004011647A1 (en) * 2002-07-26 2004-02-05 Chiron Corporation Modified small interfering rna molecules and methods of use
WO2004050829A2 (en) * 2002-08-20 2004-06-17 Aeras Global Tuberculosis Vaccine Foundation Recombinant double-stranded rna phage, and use of the same
US20040198640A1 (en) * 2003-04-02 2004-10-07 Dharmacon, Inc. Stabilized polynucleotides for use in RNA interference

Also Published As

Publication number Publication date
AP2007004020A0 (en) 2007-06-30
MX2007006366A (es) 2008-03-10
KR20070101854A (ko) 2007-10-17
CA2587493A1 (en) 2006-06-08
EP1817408A2 (en) 2007-08-15
US20060115493A1 (en) 2006-06-01
US8053568B2 (en) 2011-11-08
EA011282B1 (ru) 2009-02-27
EP1817408A4 (en) 2009-01-28
EA200701129A1 (ru) 2007-12-28
WO2006060257A3 (en) 2006-12-14
AU2005310119A1 (en) 2006-06-08
TW200631593A (en) 2006-09-16
WO2006060257A2 (en) 2006-06-08
PE20061169A1 (es) 2006-11-08
JP2008521434A (ja) 2008-06-26
EP1817408B1 (en) 2013-01-16

Similar Documents

Publication Publication Date Title
BRPI0506369A (pt) microorganismos, e, métodos para produzir um l-aminoácido
MX2010009465A (es) Una celula fermentadora de azucar pentosa.
NZ586238A (en) Methods and compositions for immunizing pigs against porcine circovirus
AR039465A1 (es) Sistema multi plasmid para la produccion de virus influenza
BRPI0719469C1 (pt) vetores de expressão derivados de retrovírus e métodos para produzir um vírus infeccioso de sarampo
NZ602958A (en) High level expression of recombinant toxin proteins
BR112012000942B8 (pt) processos para a produção de poliovírus, e para produzir uma vacina contra pólio
WO2013074059A3 (en) Cytosine deaminase modulators for enhancement of dna transfection
HRP20211170T1 (hr) Pripravci i postupci koji se odnose na mutantni toksin iz bakterije clostridium difficile
KR100469936B1 (ko) 사스 바이러스 항원의 세포표면 발현벡터 및 상기 벡터에의해 형질전환된 미생물
BRPI0518109A (pt) cepa bacteriana, nucleocapsìdeo, preparação de vacina, método para criar uma bactéria recombinante, bactéria mutante, seqüências de rna fluorado para deslanchar rdsrna e meio para eletroporação
MX2011012234A (es) Plasmido libre de antibiotico.
WO2005098016A3 (en) Methods for producing hyaluronic acid
BR0011159A (pt) Método para produzir vacinas de vìrus rna de fita negativa atenuado a partir de sequências de nucleotìdeos clonados
BRPI1004898B8 (pt) vetor expressão de superfície, microorganismo recombinate, vacina para tratar cervical e método para preparar um microorganismo
MY185050A (en) A pentose sugar fermenting cell
AU8491401A (en) Phage-dependent superproduction of biologically active protein and peptides
BRPI0507077A (pt) processo para a preparação de l-aminoácidos usando cepas da famìlia enterobacteriaceae
CN103952422B (zh) 枯草芽孢杆菌编码PRPP转酰胺酶突变基因purF及应用
BR0110987A (pt) Cepas estáveis de zymomonas mobilis fermentadoras de xilose e arabinose, transposon para inserção, estável de genes alheios dentro de um genoma bacteriano, vetor plasmìdeo contendo o referido transposon, bactéria transformada com o referido plasmìdeo, vetor pzb1862-idhl-ara atcc com número de ascenção pta-1798, elemento transponìvel mini-tn5-tal/tkt-xilaxilb atcc com número de ascenção pta-1795, cepa de bactéria g8 atcc com número de ascenção pta-1796, cepa de bactéria c25 atcc com número de ascenção pta-1799, cepa de bactéria ax atcc com número de ascenção pta-1797, mistura de reação compreendendo meio fermentável
CN101560520A (zh) 乙脑/登革嵌合病毒及其应用
NZ595833A (en) Method of producing a lipolytic enzyme
WO2011159092A3 (ko) 신규 토양 미생물과 상기 토양 미생물로부터 분리된 신규한 산화환원효소, 상기 산화환원 효소를 암호화하는 유전자 및 이들을 이용한 비당체의 생산방법
CN103429731B (zh) 具有生产n‑乙酰葡糖胺能力的棒状杆菌属微生物及用其生产n‑乙酰葡糖胺或葡糖胺的方法
MY162658A (en) Genes encoding major capsid protein l1 of human papilloma virus and use of the same

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DA 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2208 DE 30/04/2013.